Antiproliferative activity of 8-methoxypsoralen on DU145 prostate cancer cells under UVA and blue light

Photochem Photobiol Sci. 2017 Jul 1;16(7):1182-1193. doi: 10.1039/c7pp00116a. Epub 2017 Jun 12.

Abstract

The use of photoactivatable 8-methoxypsoralen (8-MOP) as potential focal treatment towards prostate cancer cells is proposed here. Our results, obtained on isolated DNA and DU145 cells, indicate that blue light, besides UVA, is able to activate 8-MOP. When compared to UVA, blue light irradiation led to a modulation of the extent and the types of 8-MOP-DNA damage, specially cross-links, coupled to a still valuable antiproliferative effect. Our data suggest that the proapototic activity of 8-MOP is related not only to DNA damage and reactive oxygen species generation but also to the modulation of cell signalling pathways. In particular, a different activation of p38 and p44/42 mitogen-activated protein kinases was detected depending on the light wavelengths.

MeSH terms

  • Antineoplastic Agents / pharmacology*
  • Cell Proliferation / drug effects
  • Cross-Linking Reagents / pharmacology*
  • Dose-Response Relationship, Drug
  • Drug Screening Assays, Antitumor
  • Humans
  • Light*
  • Male
  • Methoxsalen / pharmacology*
  • Mitogen-Activated Protein Kinases / metabolism
  • Prostatic Neoplasms / drug therapy
  • Prostatic Neoplasms / pathology*
  • Reactive Oxygen Species / metabolism
  • Structure-Activity Relationship
  • Tumor Cells, Cultured

Substances

  • Antineoplastic Agents
  • Cross-Linking Reagents
  • Reactive Oxygen Species
  • Mitogen-Activated Protein Kinases
  • Methoxsalen